Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.775 USD | -6.08% | -12.60% | -87.95% |
09/05 | Transcript : Amylyx Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 09, 2024 | |
09/05 | Amylyx Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-87.95% | 129M | |
-2.61% | 88.47B | |
+3.55% | 40.71B | |
-14.18% | 32.43B | |
+55.89% | 24.28B | |
-16.05% | 15.52B | |
-41.29% | 12.17B | |
-15.57% | 12.01B | |
-11.75% | 12B | |
+7.87% | 8.87B |
- Stock Market
- Equities
- AMLX Stock
- News Amylyx Pharmaceuticals, Inc.
- Deutsche Bank Cuts Amylyx Pharmaceuticals' Price Target to $8 From $36, Maintains Buy Rating